PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

Picard Medical, Inc.

PosiFunda Ratios Only on PositoAI

PositoAI's own ratios from Picard Medical, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.

What stands out

  • Cash Locked Ratio: For every $100 of sales, $121 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $233 tied up three years earlier. More money tied up than almost all Healthcare companies in United States.
  • Growth Efficiency Ratio: Sales grew 20% in 3 years, but profit fell: $1,915 less profit per $100 of extra sales. Lower than 97% of Healthcare companies in United States.

Where $100 of sales goes

$368Operating costs$109Interest$547Net loss

Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.

Cash quality

Profit Cash Ratio

—

Loss-making or profit too small

Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.

Self-Funding Ratio

—

Data incomplete

Cash Locked Ratio

$121

For every $100 of sales, $121 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $233 tied up three years earlier.

More money tied up than almost all Healthcare companies in United States.

Growth quality

Steadiness Ratio

2/3 · 0/3

Sales grew in 2 of the last 3 years; profit grew in 0 of 3.

Less steady than 70% of Healthcare companies in United States.

Growth Efficiency Ratio

−$1,915

Sales grew 20% in 3 years, but profit fell: $1,915 less profit per $100 of extra sales.

Lower than 97% of Healthcare companies in United States.

Asset Productivity Ratio

+20% / +46%

In 3 years sales changed by +20% while total assets changed by +46%. Assets grew faster than sales.

Balance-sheet strength

Debt Due Cover Ratio

-2.4×

Operating cash was negative last year, while some debt falls due within a year.

Higher than 63% of Healthcare companies in United States.

Cash Cushion Ratio

+3%

Cash, after subtracting all debt, equals 3% of its market value (net cash).

Lower than 63% of Healthcare companies in United States.

Tangible Assets Ratio

95%

Of every $100 the company owns, $95 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.

More tangible than 72% of Healthcare companies in United States.

Tangible Net Worth Ratio

70%

Of every $100 of net worth, $70 is tangible; the rest is goodwill and other intangibles, often from buying other companies.

More tangible than 56% of Healthcare companies in United States.

Shareholders

Shareholder Slice Ratio

+2%

Share count rose 2% in 3 years, so each share's slice of the company became smaller.

Smaller rise in share count than 80% of Healthcare companies in United States.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (12)

Picard Medical, Inc. made a loss over the last year. Picard Medical, Inc. owes $0.81 for every $1 it owns. Picard Medical, Inc. made a loss in each of the last two years.

Compared with Healthcare companies in United States · latest annual results Dec 2025.

P/E ratio

Loss

Picard Medical, Inc. made a loss over the last year, so its P/E ratio is not meaningful.

P/B ratio

10.04

The share price is 10.04 times Picard Medical, Inc.'s book value per share, higher than 86% of Healthcare companies in United States.

Market cap

$17 M

The total market value of all of Picard Medical, Inc.'s shares at today's price (share price × number of shares), smaller than 83% of Healthcare companies in United States. PosiCap size class: Micro Cap.

Net worth (book value)

$2 M

What Picard Medical, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).

Book value per share

$0.73

Net worth divided by the number of shares. The share price of $7.37 is 10.0 times this, which is the P/B above.

Owes vs Owns

0.81×

Picard Medical, Inc. owes $0.81 for every $1 it owns (high), higher than 78% of Healthcare companies in United States.

Dividend yield

None

Picard Medical, Inc. does not currently pay a dividend.

Revenue growth

+13%

Revenue rose 13% in the year to Dec 2025, and grew 6% a year on average over 3 years.

Profit growth

Loss

Picard Medical, Inc. made a loss in each of the last two years.

Profit margin

-546.6%

Picard Medical, Inc. lost $547 for every $100 of revenue.

Interest cover

Not covered

Picard Medical, Inc.'s operating profit did not cover its interest costs in the year to Dec 2025.

Cash vs debt

Net cash

Picard Medical, Inc. held $0 M more cash than debt (net cash) at Dec 2025.

Questions

How is P/B calculated on PositoAI?

P/B is market cap divided by net worth from the latest balance sheet. For Picard Medical, Inc.: $17 M ÷ $2 M (30 Jun 2026) = 10.0.

How much does Picard Medical, Inc. owe compared with what it owns?

Picard Medical, Inc. owes $0.81 for every $1 it owns (high), higher than 78% of Healthcare companies in United States.

Does Picard Medical, Inc. pay a dividend?

No. Picard Medical, Inc. does not currently pay a dividend.

Is Picard Medical, Inc.'s revenue growing?

Revenue rose 13% in the year to Dec 2025, and grew 6% a year on average over 3 years.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.